Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Ранг среди акций #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Цена акции
$0.16328419
Рыночная капитализация
$204.14K
Изменение (1 день)
4.35%
Изменение (1 год)
102.45%
Страна
GB
Торговля Fusion Antibodies plc (FAB)

Категория

Коэффициент P/S для Fusion Antibodies plc (FAB)
Коэффициент P/S на March 2026 TTM: 9.79
Согласно последним финансовым отчетам и цене акций Fusion Antibodies plc, текущий коэффициент P/S (TTM) составляет 9.79. В конце 2024 он составлял 1.88.
История P/S для Fusion Antibodies plc с 2013 по 2026
Коэффициент P/S в конце каждого года
Год P/S Изменить
2026 (TTM) 9.79 226.39%
2025 3.00 59.38%
2024 1.88 -45.47%
2023 3.45 6.43%
2022 3.24 -66.20%
2021 9.60 78.11%
2020 5.39 86.72%
2019 2.89 -54.34%
2018 6.32 -55.67%
2017 14.25 -22.61%
2016 18.42 -38.61%
2015 30.00 -20.48%
2014 37.73 -43.99%
2013 67.37 0.00%
Коэффициент P/S для аналогичных компаний или конкурентов
Компания P/S Разница P/S Страна
3.55 -63.73%
DK
9.90 1.13%
US
5.40 -44.83%
US
6.14 -37.31%
BE
12.90 31.71%
NL